CL2019000845A1 - Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar - Google Patents
Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgarInfo
- Publication number
- CL2019000845A1 CL2019000845A1 CL2019000845A CL2019000845A CL2019000845A1 CL 2019000845 A1 CL2019000845 A1 CL 2019000845A1 CL 2019000845 A CL2019000845 A CL 2019000845A CL 2019000845 A CL2019000845 A CL 2019000845A CL 2019000845 A1 CL2019000845 A1 CL 2019000845A1
- Authority
- CL
- Chile
- Prior art keywords
- prevention
- strains
- isolated
- acne vulgaris
- adjunctive treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta tecnología comprende 2 cepas aisladas desde Helix aspersa Müller las que se encuentran depositadas en la Colección Chilena de Recursos Genéticos Microbianos (CChRGM) bajo el código de acceso RGM 2678 y RGM 2679. También se presenta una formulación tópica que las contiene y su uso como probióticos para la prevención y tratamiento coadyuvante del acné vulgar.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2019000845A CL2019000845A1 (es) | 2019-03-29 | 2019-03-29 | Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar |
PCT/CL2019/050126 WO2020198895A1 (es) | 2019-03-29 | 2019-12-02 | Formulación probiótica que comprende cepas aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2019000845A CL2019000845A1 (es) | 2019-03-29 | 2019-03-29 | Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019000845A1 true CL2019000845A1 (es) | 2019-08-30 |
Family
ID=67769699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019000845A CL2019000845A1 (es) | 2019-03-29 | 2019-03-29 | Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2019000845A1 (es) |
WO (1) | WO2020198895A1 (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3795011B2 (ja) * | 2002-12-16 | 2006-07-12 | 株式会社ヤクルト本社 | 保湿剤及びこれを含有する化粧料 |
US7510734B2 (en) * | 2004-03-04 | 2009-03-31 | E-L Management Corporation | Skin treatment method with Lactobacillus extract |
FR2938437B1 (fr) * | 2008-11-19 | 2020-03-27 | Société des Produits Nestlé S.A. | Utilisation cosmetique de microorganisme pour le traitement des peaux grasses |
KR101258692B1 (ko) * | 2010-10-14 | 2013-04-29 | 대한민국 | 항생제 저항성 포도상구균(mrsa)억제 유산균 바이셀라 비리데센스 |
GB201206599D0 (en) * | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
CN104644840A (zh) * | 2015-02-10 | 2015-05-27 | 济南康众医药科技开发有限公司 | 一种治疗痤疮的药物组合物的制备方法 |
-
2019
- 2019-03-29 CL CL2019000845A patent/CL2019000845A1/es unknown
- 2019-12-02 WO PCT/CL2019/050126 patent/WO2020198895A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2020198895A1 (es) | 2020-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR106768A1 (es) | Composiciones que comprenden cepas bacterianas | |
PE20181271A1 (es) | Composiciones que comprenden cepas bacterianas | |
BR112022009600A2 (pt) | Paenibacillus peoriae fixador de nitrogênio isolado, cultura biologicamente pura de um paenibacillus peoriae fixador de nitrogênio, uso de um ou mais paenibacillus peoriae fixadores de nitrogênio e do consórcio microbiano sintético, método, composição inoculante e de sementes de ocorrência não natural, e, consórcio microbiano sintético | |
Murugesan et al. | Phytochemical screening and Antimicrobial activity of the leaves of Memecylon umbellatum burm. F. | |
AR092188A1 (es) | ANTICUERPOS HUMANOS PARA GFRa3 Y METODOS PARA SU USO | |
ES2531193T3 (es) | Cepas de levadura y métodos de utilización de las mismas | |
BR112017014052A2 (pt) | composições e métodos para uso de inseticida com d747 de bacillus sp | |
BR112017000885A2 (pt) | clonostachys rosea inoculadas em materiais vegetais com fungicidas e adjuvantes. | |
CO2020007601A2 (es) | Cepa vacunal de brucella modificada para el tratamiento de brucelosis | |
AR111885A1 (es) | Composiciones que comprenden cepas bacterianas | |
CL2019000845A1 (es) | Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar | |
PE20200295A1 (es) | Mitocetoscinas: agentes terapeuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en celulas cancerosas | |
ES2486166A1 (es) | Hongos como agentes de control biológico | |
TR201904382T4 (tr) | Vajinit tedavisi. | |
Sasmakov et al. | In vitro screening of the cytotoxic, antibacterial and antioxidant activities of some Uzbek plants used in folk medicine | |
Arora et al. | Antimicrobial potential of Moringa oleifera seed coat and its bioactive phytoconstituents | |
Wetschnig et al. | Massonia saniensis (Asparagaceae, Scilloideae), a new species from Lesotho, southern Africa | |
AR113143A1 (es) | Cepa de tolypocladium album y su uso como plaguicida biológico | |
Adugna et al. | Potential In vitro anti‑bacterial action of selected medicinal plants against Escherichia coli and three Salmonella species | |
CL2017003480A1 (es) | Mezcla de biocontroladores fúngicos para el control de hongos causales del brazo muerto de la vid | |
CO2019012690A2 (es) | Bacillus amyloliquefaciens qv15 estimulante del metabolismo secundario de compuestos fenólicos y de la capacidad inhibidora de los extractos de frambuesa y fresa sobre los enzimas relacionadas con el síndrome metabólico | |
AR112145A1 (es) | Composiciones que comprenden cepas bacterianas | |
MX2018007002A (es) | Composiciones equibioticas utiles en la reversion de la resistencia microbiana a los antibioticos. | |
Budanova | USE OF BIOLOGICALLY ACTIVE COMPOUNDS OF BLUE-GREEN ALGAE SPIRULINA PLATENSIS IN MEDICINE AND PHARMACY | |
Belaidi et al. | Antagonistic activity of three species of bacteria against Fusarium oxysporum f. sp. albedinis, the causal agent of Bayoud disease on date palm (Phoenix dactylifera L.). |